Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway
2021 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-021-99412-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
144
Citations
4
h-index
3
i10-index
Naoki Kuroda is an academic researcher from Matsunami General Hospital. The author has contributed to research in topics: Esophageal and GI Pathology & Gastrointestinal disorders and treatments & Antibiotics Pharmacokinetics and Efficacy. The author has an h-index of 4, co-authored 25 publications.
ORCID: 0000-0003-4524-4167https://doi.org/10.1038/s41598-021-99412-8
https://doi.org/10.1038/s41598-024-74215-9
Click to start Chat